Global Med Technologies(R), Inc. Clarifies Proposal Received from Victory Park Capital Advisors, LLC
December 10 2008 - 7:12PM
PR Newswire (US)
DENVER, Dec. 10 /PRNewswire-FirstCall/ -- Global Med
Technologies(R), Inc. ("Global Med" or the "Company") (OTC:GLOB)
(BULLETIN BOARD: GLOB) , an international e-Health, medical
information technology company, today announced that due to
inquiries from stockholders, Global Med is clarifying that the
letter that was received from Victory Park Capital Advisors, LLC
("VPC") on December 9, 2008 was a proposal to Global Med's Board of
Directors to investigate various business opportunities for the
Company. VPC's letter does not constitute an offer to Global Med's
shareholders to acquire the outstanding securities of Global Med
not already held by VPC. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO) About
Global Med Technologies(R), Inc. Global Med Technologies, Inc. is
an international medical software company which develops regulated
and non-regulated software products and services for the healthcare
industry. As a leading provider of blood and laboratory software
applications and services, Global Med's products are deployed in 20
countries and serve over 1,600 transfusion centers, blood banks and
laboratories. Global Med's domestic companies are Wyndgate
Technologies(R), which provides Vein-to-Vein(R) tracking through
its Donor Doc(TM), SafeTrace(R), SafeTrace Tx(R) and ElDorado
Donor(TM) software products; eDonor(R), which provides a web-based
donor relationship management system that integrates recruitment,
scheduling, retention and fulfillment for national as well as local
community blood centers and hospitals; and PeopleMed(TM), Inc.,
which implements cost-effective customized software validation,
consulting and compliance solutions to hospitals and donor centers.
Global Med's European subsidiary, Inlog, SA, is a leading developer
of donor center and transfusion management systems as well as
cellular therapy software, laboratory information systems and
quality assurance medical software systems internationally. Inlog's
products include EdgeBlood*, EdgeTrack*, EdgeCell, EdgeLab and
SapaNet. For more information about Global Med's products and
services, please call 800-996-3428 or visit
http://www.globalmedtech.com/, http://www.peoplemed.com/,
http://www.inlog.com/, http://www.edonor.com/, and
http://www.wyndgate.com/. *FDA 510(k) clearance required prior to
sales in the U.S. This news release may include statements that
constitute forward-looking statements, usually containing the words
"believe," "estimate," "project," "expects" or similar expressions.
These statements are made pursuant to the safe harbor provisions of
the Private Securities Litigation Reform Act of 1995.
Forward-looking statements inherently involve risks and
uncertainties that could cause actual results to differ materially
from the forward-looking statements. By making these
forward-looking statements, the Company undertakes no obligation to
update these statements for revisions or changes after the date of
this news release.
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies,
Inc. CONTACT: Michael I. Ruxin, M.D., of Global Med Technologies,
Inc., +1-303-238-2000, ; or Investors, Paul Holm, President of
portfolio pr, +1-212-888-4570, , for Global Med Technologies, Inc.
Web site: http://www.globalmedtech.com/
Copyright